{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:06:56Z","timestamp":1788336416788,"version":"build-2803163510"},"reference-count":62,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Leukemic stem cells (LSCs) in acute myeloid leukemia (AML) depend on oxidative phosphorylation (OXPHOS) sustained by fatty acid oxidation (FAO) and mitochondrial fusion (mitofusion). In this study, we demonstrate that microRNA-126 (miR-126) maintains LSC function by promoting B-cell lymphoma 2 (BCL-2)\u2013dependent FAO, OXPHOS, and mitofusion, whereas its inhibition disrupts mitochondrial metabolism, induces mitochondrial fission (mitofission), and triggers apoptosis. Mechanistically, miR-126 stabilizes BCL-2 through the SPRED1\/extracellular signal-regulated kinase axis, which upregulates CPT1B (FAO) and NRF2 (antioxidant response) while regulating mitochondrial dynamics through DRP1 phosphorylation (inhibiting mitofission) and MFN1\/2 phosphorylation (enhancing mitofusion). miRisten, a CpG-conjugated anti\u2013miR-126 oligonucleotide now in clinical trials (NCT07025564), synergized with venetoclax (VEN) to suppress FAO\/OXPHOS, promote mitofission, and impair LSC homeostasis. In vivo, miRisten potentiated the VEN\/azacitidine regimen, an US Food and Drug Administration-approved therapy for older or unfit patients with AML, significantly prolonging survival in patient-derived xenograft models. VEN\/miRisten combination also reduced LSC burden and restored VEN sensitivity, establishing miR-126 inhibition as a transformative therapeutic strategy for AML.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025029875","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:34:47Z","timestamp":1765834487000},"page":"1083-1097","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-0088","authenticated-orcid":false,"given":"Lianjun","family":"Zhang","sequence":"first","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyunJun","family":"Kang","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Valerio","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Hoa","family":"Hoang","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khyatiben","family":"Pathak","sequence":"additional","affiliation":[{"name":"2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ"},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystine","family":"Garcia-Mansfield","sequence":"additional","affiliation":[{"name":"2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ"},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"4Department of Nutritional Sciences, Dell Pediatric Research Institute, The University of Texas at Austin, Austin, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wancheng","family":"Guo","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-2961","authenticated-orcid":false,"given":"Yu-Hsuan","family":"Fu","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"},{"name":"5Irell and Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chieh","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1381-0235","authenticated-orcid":false,"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[{"name":"6Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ghoda","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Buettner","sequence":"additional","affiliation":[{"name":"7Hematology Malignancies Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[{"name":"8Beckman Research Institute, Electron Microscopy Core Facility, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Blackmon","sequence":"additional","affiliation":[{"name":"9Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4703-7524","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-6039","authenticated-orcid":false,"given":"Patrick","family":"Pirrotte","sequence":"additional","affiliation":[{"name":"2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ"},{"name":"3Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-0419","authenticated-orcid":false,"given":"Ya-Huei","family":"Kuo","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Xuan Truong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA"},{"name":"2Early Detection and Prevention Division, Translational Genomics Research Institute, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2026030511221570500_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41408-018-0087-2","article-title":"Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia","volume":"8","author":"Laverdi\u00e8re","year":"2018","journal-title":"Blood Cancer J"},{"issue":"5","key":"2026030511221570500_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","article-title":"Targeting leukemic stem cells by breaking their dormancy","volume":"4","author":"Essers","year":"2010","journal-title":"Mol Oncol"},{"issue":"11","key":"2026030511221570500_bib3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"13","key":"2026030511221570500_bib4","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","article-title":"Stem cell concepts renew cancer research","volume":"112","author":"Dick","year":"2008","journal-title":"Blood"},{"issue":"13","key":"2026030511221570500_bib5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood-2014-08-594408","article-title":"AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress","volume":"125","author":"Sriskanthadevan","year":"2015","journal-title":"Blood"},{"issue":"13","key":"2026030511221570500_bib6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood.2019003654","article-title":"Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells","volume":"136","author":"Raffel","year":"2020","journal-title":"Blood"},{"issue":"5","key":"2026030511221570500_bib7","doi-asserted-by":"crossref","first-page":"e45432","DOI":"10.15252\/embr.201745432","article-title":"Mitochondria and the dynamic control of stem cell homeostasis","volume":"19","author":"Lisowski","year":"2018","journal-title":"EMBO Rep"},{"issue":"1","key":"2026030511221570500_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2026030511221570500_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2026030511221570500_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"2026030511221570500_bib11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat Med"},{"issue":"516","key":"2026030511221570500_bib12","doi-asserted-by":"crossref","first-page":"eaax2863","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci Transl Med"},{"issue":"9","key":"2026030511221570500_bib13","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.3324\/haematol.2018.188094","article-title":"Efficacy of the combination of venetoclax and hypomethylating agents in relapsed\/refractory acute myeloid leukemia","volume":"103","author":"Aldoss","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2026030511221570500_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-021-00870-3","article-title":"Activation of RAS\/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"2026030511221570500_bib15","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Cancer Discov"},{"key":"2026030511221570500_bib16","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2026030511221570500_bib17","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.3324\/haematol.2022.281214","article-title":"Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-na\u00efve acute myeloid leukemia","volume":"107","author":"Gangat","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"2026030511221570500_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ajh.27138","article-title":"Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: genotype signatures for response and survival among 301 consecutive patients","volume":"99","author":"Gangat","year":"2024","journal-title":"Am J Hematol"},{"issue":"1","key":"2026030511221570500_bib19","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.clnves.2025.100007","article-title":"Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia","volume":"1","author":"Hou","year":"2025","journal-title":"Cell Investigation"},{"issue":"7","key":"2026030511221570500_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/2159-8290.CD-19-0117","article-title":"Targeting mitochondrial structure sensitizes acute myeloid leukemia to venetoclax treatment","volume":"9","author":"Chen","year":"2019","journal-title":"Cancer Discov"},{"issue":"12","key":"2026030511221570500_bib21","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"issue":"5","key":"2026030511221570500_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","article-title":"Inhibition of amino acid metabolism selectively targets human leukemia stem cells","volume":"34","author":"Jones","year":"2018","journal-title":"Cancer Cell"},{"issue":"11","key":"2026030511221570500_bib23","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s43018-021-00264-y","article-title":"Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia","volume":"2","author":"Bosc","year":"2021","journal-title":"Nat Cancer"},{"issue":"1","key":"2026030511221570500_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-021-01076-4","article-title":"Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine","volume":"14","author":"Buettner","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2026030511221570500_bib25","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2016-10-697698","article-title":"MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts","volume":"130","author":"Wallace","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2026030511221570500_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/cbin.10770","article-title":"MicroRNA: an important regulator in acute myeloid leukemia","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Biol Int"},{"issue":"4","key":"2026030511221570500_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ccell.2016.03.015","article-title":"miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells","volume":"29","author":"Lechman","year":"2016","journal-title":"Cancer Cell"},{"issue":"4","key":"2026030511221570500_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm.4499","article-title":"Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"2026030511221570500_bib29","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1038\/s41467-021-26420-7","article-title":"Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2026030511221570500_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-021-01133-y","article-title":"Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2026030511221570500_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccr.2005.12.014","article-title":"Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia","volume":"9","author":"Kuo","year":"2006","journal-title":"Cancer Cell"},{"issue":"11","key":"2026030511221570500_bib32","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2016-01-693119","article-title":"CBFbeta-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice","volume":"128","author":"Cai","year":"2016","journal-title":"Blood"},{"issue":"24","key":"2026030511221570500_bib33","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1242\/dev.029736","article-title":"Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126","volume":"135","author":"Kuhnert","year":"2008","journal-title":"Development"},{"issue":"5229","key":"2026030511221570500_bib34","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"issue":"6","key":"2026030511221570500_bib35","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-07-098749","article-title":"MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia","volume":"111","author":"Garzon","year":"2008","journal-title":"Blood"},{"issue":"40","key":"2026030511221570500_bib36","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0808266105","article-title":"Distinct microRNA expression profiles in acute myeloid leukemia with common translocations","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2026030511221570500_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ajh.21667","article-title":"Differential expression of specific microRNA and their targets in acute myeloid leukemia","volume":"85","author":"Cammarata","year":"2010","journal-title":"Am J Hematol"},{"issue":"8","key":"2026030511221570500_bib38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","article-title":"TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal","volume":"30","author":"Li","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"24","key":"2026030511221570500_bib39","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1182\/blood-2012-12-475483","article-title":"Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy","volume":"121","author":"Boyerinas","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2026030511221570500_bib40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/stem.2308","article-title":"miR-126-3p promotes matrix-dependent perivascular cell attachment, migration and intercellular interaction","volume":"34","author":"Pitzler","year":"2016","journal-title":"Stem Cells"},{"issue":"2","key":"2026030511221570500_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev Cell"},{"issue":"6847","key":"2026030511221570500_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/35088082","article-title":"Spred is a Sprouty-related suppressor of Ras signalling","volume":"412","author":"Wakioka","year":"2001","journal-title":"Nature"},{"issue":"1-3","key":"2026030511221570500_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.febslet.2004.06.003","article-title":"The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria","volume":"569","author":"Tamura","year":"2004","journal-title":"FEBS Lett"},{"issue":"5","key":"2026030511221570500_bib44","doi-asserted-by":"crossref","first-page":"e2226","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell Death Dis"},{"issue":"3","key":"2026030511221570500_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/bbrc.1997.6089","article-title":"Direct interaction of the mitochondrial membrane protein carnitine palmitoyltransferase I with Bcl-2","volume":"231","author":"Paumen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2026030511221570500_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.surg.2023.12.019","article-title":"CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1\/NRF2 axis in pancreatic cancer","volume":"175","author":"Tuerhong","year":"2024","journal-title":"Surgery"},{"issue":"1","key":"2026030511221570500_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/MCB.25.1.162-171.2005","article-title":"BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase","volume":"25","author":"Furukawa","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"18","key":"2026030511221570500_bib48","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/ars.2016.6855","article-title":"The Keap1-Nrf2 stress response pathway promotes mitochondrial hyperfusion through degradation of the mitochondrial fission protein Drp1","volume":"27","author":"Sabouny","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2026030511221570500_bib49","doi-asserted-by":"crossref","first-page":"20230711","DOI":"10.1515\/med-2023-0711","article-title":"Nrf2 protects against myocardial ischemia-reperfusion injury in diabetic rats by inhibiting Drp1-mediated mitochondrial fission","volume":"18","author":"Wang","year":"2023","journal-title":"Open Med"},{"issue":"2","key":"2026030511221570500_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.molcel.2015.02.021","article-title":"Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis","volume":"58","author":"Pyakurel","year":"2015","journal-title":"Mol Cell"},{"issue":"3","key":"2026030511221570500_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jb\/mvg150","article-title":"Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion","volume":"134","author":"Eura","year":"2003","journal-title":"J Biochem"},{"issue":"2","key":"2026030511221570500_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.200211046","article-title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development","volume":"160","author":"Chen","year":"2003","journal-title":"J Cell Biol"},{"issue":"8","key":"2026030511221570500_bib53","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1002\/jcp.28091","article-title":"The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML","volume":"234","author":"Nguyen","year":"2019","journal-title":"J Cell Physiol"},{"key":"2026030511221570500_bib54","doi-asserted-by":"crossref","first-page":"2040620719882822","DOI":"10.1177\/2040620719882822","article-title":"Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy","volume":"10","author":"Richard-Carpentier","year":"2019","journal-title":"Ther Adv Hematol"},{"issue":"7","key":"2026030511221570500_bib55","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","article-title":"Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia","volume":"13","author":"Glytsou","year":"2023","journal-title":"Cancer Discov"},{"issue":"3","key":"2026030511221570500_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov"},{"issue":"5","key":"2026030511221570500_bib57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1535-7163.MCT-15-0730","article-title":"Expression profile of BCL-2, BCL-XL, and MCL-1 predicts pharmacological response to the BCL-2 selective antagonist venetoclax in multiple myeloma models","volume":"15","author":"Punnoose","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"22","key":"2026030511221570500_bib58","doi-asserted-by":"crossref","first-page":"e170169","DOI":"10.1172\/JCI170169","article-title":"Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies","volume":"133","author":"Chong","year":"2023","journal-title":"J Clin Invest"},{"issue":"12","key":"2026030511221570500_bib59","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"2026030511221570500_bib60","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41375-023-01933-w","article-title":"Targeting miR-126 in Ph+ acute lymphoblastic leukemia","volume":"37","author":"Qiao","year":"2023","journal-title":"Leukemia"},{"issue":"6","key":"2026030511221570500_bib61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41419-024-06810-7","article-title":"Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia","volume":"15","author":"Nwosu","year":"2024","journal-title":"Cell Death Dis"},{"issue":"8041","key":"2026030511221570500_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41586-024-08137-x","article-title":"RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax","volume":"636","author":"Sango","year":"2024","journal-title":"Nature"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/10\/1083\/2506892\/blood_bld-2025-029875-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/10\/1083\/2506892\/blood_bld-2025-029875-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:22:31Z","timestamp":1772727751000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/10\/1083\/557332\/Pharmacological-inhibition-of-miR-126-enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029875","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,5]]},"published":{"date-parts":[[2026,3,5]]}}}